SCHEMBL6817201

SCHEMBL6817201

CCOc1cc(Nc2ccc(Br)cc2NC(=O)CCC(=O)O)ccc1C(=S)c1ccccc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
MAPK1 P28482 2/20 0.43
MAPK13 O15264 2/20 0.41
MAPK12 P53778 2/20 0.41
MAPK11 Q15759 2/20 0.41
MAPK14 Q16539 2/20 0.41
GAA P10253 2/20 0.40
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 2/20 0.39
THRB P10828 1/20 0.38
MAPT P10636 3/20 0.38
POLB P06746 3/20 0.38
HPGD P15428 2/20 0.38
ALOX12 P18054 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6817204 1.00 CYP2C19 (0.46) CYP2C19SMN1; SMN2MAPK1MAPK13MAPK12
SCHEMBL6817802 0.91 MAPK1 (0.48) CYP2C19SMN1; SMN2MAPK1MAPK13MAPK12
SCHEMBL6817801 0.91 MAPK1 (0.48) CYP2C19SMN1; SMN2MAPK1MAPK13MAPK12
SCHEMBL6820656 0.86 MAPK1 (0.46) CYP2C19SMN1; SMN2MAPK1MAPK13MAPK12
SCHEMBL6817328 0.83 MAPT (0.44) CYP2C19SMN1; SMN2MAPK1MAPK13MAPK12
SCHEMBL6904569 0.82 MAPK13 (0.52) SMN1; SMN2MAPK13MAPK12MAPK11MAPK14
SCHEMBL6817758 0.79 MAPK1 (0.48) CYP2C19SMN1; SMN2MAPK1MAPK13MAPK12
SCHEMBL6817754 0.79 MAPK1 (0.48) CYP2C19SMN1; SMN2MAPK1MAPK13MAPK12
SCHEMBL6817036 0.79 MAPK1 (0.52) CYP2C19SMN1; SMN2MAPK1MAPK13MAPK12
SCHEMBL6094767 0.79 MAPK14 (0.66) CYP2C19MAPK1MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1210320-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2004-09-29 EP claimed
US-6566554-B1 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2003-05-20 US claimed
EP-1210320-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2004-09-29 EP disclosed
US-6566554-B1 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2003-05-20 US disclosed